Table 3 Challenges organised by step in the automated reanalysis process, coded to the CFIR, matched to top rated ERIC strategies and experience-based example of the strategy.
From: Reanalysis of genomic data, how do we do it now and what if we automate it? A qualitative study
Step | Challenges | CFIR code | Top rated ERIC strategies | Experience-based example |
|---|---|---|---|---|
Step 1 Patient consented for reanalysis at primary test | Unknown consent process. How to opt out, reconsent at age of transition, or analysis scope is broadened, and when offered in mainstream services | Design, Quality & Packaging | Promote adaptability | Clinical team education …clarity around the lab processes and good education to the different clinical units about the process so they can then interpret that in a way that they can educate their patients. GC14 |
Develop educational materials | ||||
Obtain & use patient/consumer/family feedback | ||||
Step 2 Automated pipeline triggered | Updating clinical information. No mechanism to update the pipeline with new clinical information | Available Resources | Access new funding | A clinical information feed platform and teamworking with primary care physicians Unless, you have some amazing platform that allows physicians and health care providers who have ongoing contact with the patient and family to be able to add in additional information. GC18 |
Change physical structure & equipment | ||||
Fund & contract for clinical innovation | ||||
Trust in the automated pipeline. That the pipeline is triggered and performs as expected | Knowledge & Beliefs | Conduct educational meetings | Local champions at services …it won’t be until it is implemented then people will see the benefit and that instils trust…I think having champions at each site that are really engaged with the project and can help almost guide those clinicians. GC14 | |
Identify & prepare champions | ||||
Develop educational materials | ||||
Executing | Purposely re-examine the implementation | An audit process From our [the laboratory] point of view how do we sufficiently engage the software to know that the right things are being completed and then making a log of that process. Lab10 | ||
Develop & implement tools for quality monitoring | ||||
Provide local technical assistance | ||||
Step 3 Variant curation | Unknown laboratory workforce implications and skills shortage. | Executing | Purposely re-examine the implementation | Develop and test the pipeline It comes down to having the right tool that allows us [the laboratory] a fairly hands free or even eyes free way of knowing what we need to follow-up. Lab11 |
Develop & implement tools for quality monitoring | ||||
Provide local technical assistance | ||||
Step 4 Clinical interpretation | Clinical workforce capacity. Lack of funding towards attending Multi-Disciplinary Team (MDTs) meetings | Available Resources | Access new funding | Additional renumeration We already are involved in attending MDTs but our role is going to evolve … especially as patients are now going to be having reanalysis through our services, as long as that is funded and acknowledged. CG05 |
Step 5 Clinician informed about the result | Ensuring the report is received by a clinician who can action it. | Compatibility | Promote adaptability | Reporting pathway The lab would need to have an agreement with each department…where there was a monitored inbox where reanalysed reports go so that if someone moves on or is on maternity leave for a year that report doesn’t get lost in the ether. GC06 |
Conduct local consensus discussions | ||||
Conduct cyclical small tests of change | ||||
Step 6 Into medical records | None reported | |||
Step 7 Patient informed about the result | Clinical workforce implications. Managing expectations, locating patients/families and, results return appointments | Individual Stage of Change | Identify and prepare champions | Staffing levels and workforce infrastructure You wouldn’t always need clinical geneticist to be involved in the return of results to families, skilled genetic counsellors can be involved in that process. So thinking about how to best utilise the workforce. CG03 |
Make training dynamic | ||||
Alter incentive/allowance structures | ||||
Processes for recontacting patients/ families. | Executing | Purposely re-examine the implementation | A national approach If there was sone kind of national approach or database where we could track patients down easier GC17 | |
Develop & implement tools for quality monitoring | ||||
Provide local technical assistance | ||||
Funded reanalysis programme | Lack of an appropriate funding model. | External policies & incentives | Involve executive boards | Appropriate funding model You would need a completely new funding model. It needs to work at scale, so the more samples you process, each individual one becomes cheaper to get each answer. CG01 |
Alter incentive/allowance structures | ||||
Build a coalition |